Join Growin Stock Community!

Inspire veterinary partners, inc.IVP.US Overview

US StockConsumer Cyclical
(No presentation for IVP)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

IVP AI Insights

IVP Overall Performance

IVP AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

IVP Recent Performance

-

Inspire veterinary partners, inc.

-1.91%

Avg of Sector

-0.31%

S&P500

IVP PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

IVP Key Information

IVP Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

IVP Profile

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.

Price of IVP

IVP FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

IVP Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-4.73
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.26
PB Ratio
0.08
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
19.36%
Net Margin
-76.75%
Revenue Growth (YoY)
-8.76%
Profit Growth (YoY)
3.89%
3-Year Revenue Growth
13.86%
3-Year Profit Growth
1.64%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-4.73
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.26
PB Ratio
0.08
Price-to-FCF
-
Gross Margin
19.36%
Net Margin
-76.75%
Revenue Growth (YoY)
-8.76%
Profit Growth (YoY)
3.89%
3-Year Revenue Growth
13.86%
3-Year Profit Growth
1.64%
  • When is IVP's latest earnings report released?

    The most recent financial report for Inspire veterinary partners, inc. (IVP) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating IVP's short-term business performance and financial health. For the latest updates on IVP's earnings releases, visit this page regularly.

  • What is the operating profit of IVP?

    According to the latest financial report, Inspire veterinary partners, inc. (IVP) reported an Operating Profit of -1.97M with an Operating Margin of -45.58% this period, representing a growth of 11.99% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is IVP's revenue growth?

    In the latest financial report, Inspire veterinary partners, inc. (IVP) announced revenue of 4.32M, with a Year-Over-Year growth rate of 6.6%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does IVP have?

    As of the end of the reporting period, Inspire veterinary partners, inc. (IVP) had total debt of 17.12M, with a debt ratio of 0.71. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does IVP have?

    At the end of the period, Inspire veterinary partners, inc. (IVP) held Total Cash and Cash Equivalents of 341.75K, accounting for 0.01 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does IVP go with three margins increasing?

    In the latest report, Inspire veterinary partners, inc. (IVP) did not achieve the “three margins increasing” benchmark, with a gross margin of 18.2%%, operating margin of -45.58%%, and net margin of -58.5%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess IVP's profit trajectory and future growth potential.

  • Is IVP's EPS continuing to grow?

    According to the past four quarterly reports, Inspire veterinary partners, inc. (IVP)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.41. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of IVP?

    Inspire veterinary partners, inc. (IVP)'s Free Cash Flow (FCF) for the period is -1.33M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 79.06% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.